Latest Blogs

Apr 21, 2017
The new Education Council will ensure that ASCO’s educational goals and strategies match its programs, and will evaluate collaboration across ASCO’s education portfolio.
Apr 20, 2017
Get the most out of your experience at the ASCO Annual Meeting by making preparations and familiarizing yourself with the program and materials before you arrive in Chicago.
Apr 18, 2017
I want to thank and pay tribute to the oncology nurses who are a true blessing and essential to providing exceptional care for my patients.
Apr 14, 2017
When faced with a suffering patient and family, it can be all too easy to blame yourself for their pain. Dr. Nasser Hanna encourages you to remember that the cancer is at fault, not you.
Subscribe to this column

Don S. Dizon, MD, FACP

Don S. Dizon, MD, FACP, is an Associate Professor at Harvard Medical School and is Clinical Co-Director of Gynecologic Oncology at the Massachusetts General Hospital (MGH) Cancer Center, where he also is Founder and Director of the Oncology Sexual Health Clinic. Dr. Dizon serves as Chair for ASCO's Social Media Working Group and is Immediate Past Chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for MGH and a Section Editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and Editor in Chief of the ASCO Educational Book. Follow Dr. Dizon on Twitter @drdonsdizon.

Mar 31, 2017
When a dying patient wanted more time at any cost, and our team collectively felt that a code would be inhumane, an ethics consultation helped provide clarity and support for our decision-making.
Mar 16, 2017
I tend to be cautious with the word cure, because sometimes that is the only thing that patients hear.
Feb 23, 2017
When the travel ban was announced, I worried for my patients and for my colleagues. I worried that medical care would be denied to international patients, including those who came to the U.S. for cancer care.
Feb 02, 2017
When it comes to many alternative therapies, the data is too sparse to inform discussions on benefits and/or risks, as my patient learned when her supplement use prevented her from continuing on a clinical trial.
Dec 27, 2016
With new therapies, fortunately, oncologists are now seeing patients over the span of years, and we get to know the person who is the patient beyond their illness. Many also bring along others on visit after visit, and we get to know each of them too.
Dec 14, 2016
As we move forward in oncology, my hope is that we will see miraculous recoveries more often, guided not by chance but by a better understanding of cancer biology. The promise of precision medicine remains a real one that I firmly believe in.

Pages